Trimethroprim-Sulfamethoxazole-Induced Dress Syndrome

Síndrome Dress por uso de Trimetropin Sulfametoxazol

The term DRESS was introduced in 1996 to describe a drug reaction with eosinophilia, skin eruption and systemic symptoms. Potentially fatal drug reactions include three distinct entities: DRESS syndrome, acute generalized exanthem and Stevens-Johnson syndrome/toxic epidermal necrolysis. We report a case of DRESS syndrome in a female patient who attended Hospital de San José in Bogotá, for presenting a cutaneous reaction induced by trimethroprim/sulfamethoxazole. The physiopathology, diagnosis, clinical features and treatment, are outlined herein.

1. Callot V, Roujeau JC, Bagot M, Wechsler J, et al. Druginduced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch Dermatol. 1996;132(11):1315–1321.
2. Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L. The DRESS Syndrome: A Literature Review. Am J Med. 2011;124(7):588-97. doi: 10.1016/j.amjmed.2011.01.017
3. Bellón T. Mechanisms of Severe Cutaneous Adverse Reactions: Recent Advances. Drug Saf. 2019;42(8):973-992. doi: 10.1007/s40264-019-00825-2
4. Choquet-Kastylevsky G, Intrator L, Chenal C, Bocquet H, Revuz J, Roujeau JC. Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome. Br J Dermatol. 1998;139(6):1026-32. doi: 10.1046/j.1365-2133.1998.02559.x
5. Lonjou C, Thomas L, Borot N, et al. A marker for Stevens- Johnson syndrome: ethnicity matters. Pharmacogenomics J. 2006;6(4):265–268. doi: 10.1038/sj.tpj.6500356
6. Kano Y, Shiohara T. Sequential reactivation of herpesvirus in drug-induced hypersensitivity syndrome. Acta Derm Venereal. 2004;84(6):484–485.
7. Quintero-Martínez DC, Flores-Arizmendi RA, Torres-Rodríguez L. Síndrome de DRESS asociado con carbamazepinaDRESS syndrome associated with carbamazepine. Bol Med Hosp Infant Mex. 2015;72(2):2-6. https://doi.org/10.1016/j.bmhimx.2015.03.007
8. Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, el at. The DRESS syndrome: a literature review. Am J Med. 2011;124(7): 588-597. doi: 10.1016/j.amjmed.2011.01.017
9. Husain Z, Reddy By, Schwartz RA. DRESS syndrome: Part 1 Clinical perspectives. Am Acad Dermatol 2013;68(5):693.e1-14. doi: 10.1016/j.jaad.2013.01.033
10. Peyriere H, Dereure O, Breton H, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. Br J Dermatol. 2006;155(2):422–428. doi: 10.1111/j.1365-2133.2006.07284.x
11. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest. 1988;82(6):1826-32. doi: 10.1172/JCI113798
12. Cabrera H. Síndrome de hipersensibilidad a la sulfasalazina. Act Terap Dermatol. 2002;25:250.
13. TICSE AGUIRRE, Ray et al. Síndrome de hipersensibilidad por uso de Trimetoprim/sulfametoxazol: Reporte de un caso. Rev Med Hered. 2006;17(2):109-114.
14. Karpman E, Kurzrock EA. Adverse reactions of nitrofurantoin, trimethoprim and sulfamethoxazole in children. J Urol. 2004;172(2):448-453. doi: 10.1097/01.ju.0000130653.74548.d6